It has been reported that not only α1A- but also α1D-adrenoreceptor antagonists effectively treat male LUTS and BPH-related symptoms, but the α1D-relevant mechanism has not been fully elucidated. The gene discussed is SERPINA1; the disease is benign prostatic hyperplasia.